
LMAT
USDLeMaitre Vascular Inc. Common Stock
السعر في الوقت الحقيقي
مخطط الأسعار
المقاييس الرئيسية
مقاييس السوق
الافتتاح
$83.000
الأعلى
$89.010
الأدنى
$81.570
الحجم
0.06M
أساسيات الشركة
القيمة السوقية
2.0B
الصناعة
Medical Instruments & Supplies
البلد
United States
إحصاءات التداول
متوسط الحجم
0.17M
البورصة
NGM
العملة
USD
نطاق 52 أسبوعاً
تقرير تحليل الذكاء الاصطناعي
آخر تحديث: ٣٠ أكتوبر ٢٠٢٥LMAT Analysis: LeMaitre Vascular Faces Key Inflection Point Ahead of Earnings
Price Action: Volatility and Support Testing
LeMaitre Vascular (LMAT) has experienced a rollercoaster ride over the past three months. The stock surged from $81 to $93.04 in early August (+15%) but later dropped to $84.66 in late September (-9%), only to stabilize near $88.55 as of October 30. Key patterns to note:
- Support Zone Alert: The stock hovers near $89.16, a critical support level. Recent lows on October 29 ($88.33) and October 30 ($87.82) suggest sellers are testing this level.
- Volume Contrasts: Surge days (August 6: +18%, volume 428,600) contrast sharply with the 509,700 volume crash on August 26 (-5%), indicating emotional retail trader involvement.
- Technical Tug-of-War: Mixed signals - the MACD "death cross" warns of bearish momentum, while the OBV spike on October 30 shows sudden buying pressure.
Sentiment: Analysts Push Against Market Skepticism
- Positive Catalyst: Barrington Research reiterated its $95 price target on October 15, implying 7.2% upside from current levels. 8 analysts collectively project a $104.62 average target (+17.9% potential).
- Earnings Countdown: The company’s Q3 results (November 6) create a natural inflection point. Historical volatility around reporting dates could amplify moves post-announcement.
- Market Disconnect: Despite the analyst optimism, the stock underperforms its 52-week high ($109.58) by 19% and trades below its P/E ratio of 40.81, which the model flags as "neutral" (not overvalued nor undervalued).
Predictive Outlook: AI Detects Short-Term Momentum
AI models project a cautious upside over 3 days:
- Day 1: +0.2% (flat move, low confidence)
- Day 2: +2.6% (strongest signal)
- Day 3: +2.3% (sustained momentum) Combined with the $91.57 AI target, this suggests potential rebound energy if support at $89.16 holds. However, the technical DMI (-DI 12.5 vs. +DI 8.8) warns of unresolved bearish pressure.
Strategic Guidance: Play the Range, Watch Debt Shadows
Entry Opportunities: If volume surges above 150,000, consider nibbling at shares near the support cluster ($89.09-$90.30). The technical setup favors a bounce, but the high debt-to-equity ratio (51.
أخبار ذات صلة
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $95 Price Target
Barrington Research analyst Michael Petusky maintains LeMaitre Vascular with a Outperform and maintains $95 price target.
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025, after the market
تنبؤ الذكاء الاصطناعيBeta
توصية الذكاء الاصطناعي
تم التحديث في: ١٠ نوفمبر ٢٠٢٥، ١٠:٣٧ ص
63.1% الثقة
المخاطر والتداول
نقطة الدخول
$86.47
جني الأرباح
$88.43
وقف الخسارة
$78.02
العوامل الرئيسية
أسهم ذات صلة
VRDN
Viridian Therapeutics Inc.
MPLX
MPLX LP Common Units Representing Limited Partner Interests
BRY
Berry Corporation (bry)
SDSTW
Stardust Power Inc. Warrant
EMO
ClearBridge Energy Midstream Opportunity Fund Inc.
ابق على اطلاع
تعيين تنبيهات الأسعار، الحصول على تحديثات تحليل الذكاء الاصطناعي وأخبار السوق في الوقت الحقيقي.